BRIDGEBIO PHARMA INC's ticker is and the CUSIP is 10806XAB8. A total of 33 filers reported holding BRIDGEBIO PHARMA INC in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $1,157,000 | +8.3% | 1,950,000 | 0.0% | 0.16% | -6.0% |
| Q2 2022 | $1,068,000 | -8.7% | 1,950,000 | 0.0% | 0.17% | +10.6% |
| Q1 2022 | $1,170,000 | -18.9% | 1,950,000 | 0.0% | 0.15% | +4.9% |
| Q4 2021 | $1,443,000 | -47.0% | 1,950,000 | 0.0% | 0.14% | -66.1% |
| Q3 2021 | $2,725,000 | -14.9% | 1,950,000 | 0.0% | 0.42% | -13.6% |
| Q2 2021 | $3,201,000 | -0.5% | 1,950,000 | 0.0% | 0.49% | -15.0% |
| Q1 2021 | $3,216,000 | – | 1,950,000 | – | 0.58% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | 49,655,000 | $82,515,000 | 3.29% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 80,000,000 | $131,952,000 | 2.77% |
| Aequim Alternative Investments LP | 22,000,000 | $36,397,000 | 2.35% |
| WOLVERINE ASSET MANAGEMENT LLC | 66,696,000 | $110,306,000 | 0.93% |
| Polar Asset Management Partners Inc. | 50,000,000 | $82,872,000 | 0.82% |
| Castle Creek Arbitrage, LLC | 6,500,000 | $10,746,000 | 0.62% |
| Soleus Capital Management, L.P. | 1,950,000 | $3,216,000 | 0.58% |
| WESTWOOD HOLDINGS GROUP INC | 16,000,000 | $26,497,000 | 0.27% |
| Nicholas Investment Partners, LP | 2,100,000 | $3,464,000 | 0.24% |
| Magnetar Financial LLC | 14,500,000 | $24,028,000 | 0.23% |